Dr. Silvia Vidal discusses immunological mechanisms in multiple myeloma with anti-CD38 antibodies
Dr. Silvia Vidal, head of the Inflammatory Diseases group at the Sant Pau Research Institute, participated in the "Immunotherapy & Hemopathies 2023" course, where she spoke about the immunological...